Multiple myeloma is characterised by the proliferation of clonal plasma cells, usually resulting in the production of a paraprotein and end-organ damage. The diagnostic criteria for multiple myeloma were set out by the International Myeloma Working Group in 2014 (Rajkumar et al., 2014).

Diagnostic Criteria

  • Bone marrow plasma cells >10% or biopsy-proven bony or extramedullary plasmacytoma; and
  • Any one of the following evidence of end-organ damage or myeloma-defining events:
    • Hypercalcemia: serum calcium >0.25 mmol/L higher than the upper limit of normal or >2.75 mmol/L.
    • Renal insufficiency: creatinine clearance <40 mL/min or serum creatinine >177mol/L.
    • Anemia: hemoglobin value of >2g/dL below the lowest limit of normal, or a hemoglobin value <10g/dL.
    • Bone lesions: one or more osteolytic lesion on skeletal radiography, CT, or PET/CT. If bone marrow has <10% clonal plasma cells, more than one bone lesion is required to distinguish from solitary plasmacytoma with minimal marrow involvement.
    • Bone marrow plasma cells >60%.
    • Serum involved / uninvolved free light chain ratio of 100 or greater, provided the absolute level of the involved light chain is at least 100mg/L.
    • More than one focal lesion on MRI that is at least 5mm or greater in size.

Peripheral Blood Features

Peripheral blood film from a patient with multiple myeloma, showing increased background staining, rouleux formation and a circulating plasma cell.
  • Rouleux formation
  • Increased backgroudn staining
  • May have circulating plasma cells (rare)
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x

Bone Marrow Features

Bone marrow aspirate from a patient with multiple myeloma, showing infiltration by numerous plasma cells.
Bone marrow aspirate from a patient with myeloma, showing two immature plasma cells with prominent nucleoli and dispersed nuclear chromatin.
Bone marrow aspirate from a patient with myeloma, showing a flame cell (plasma cells with vermillion-staining glycogen-rich IgA).
Bone marrow aspirate from a patient with myeloma, showing a pseudo-Gaucher cell (plasma cells with overstuffed fibrils). The fibrils give the cytoplasm a wispy appearance, resembling that of a Gaucher cell.
Bone marrow aspirate from a patient with multiple myeloma showing a Mott Cell containing a few Russell bodies, crystalised deposits of immunoglobulin.
  • Plasma cell >10%
  • Plasma cell infiltrate may be patchy. Distribution may be in:
    • Diffuse sheets.
    • Interstitial.
    • Small clusters.
    • Focal nodules.
  • Plasma cells may range from normal in appearance to immature with dispersed nuclear chromatin and prominent nucleoli (plasmablasts).
  • Other abnormalities in plasma cells can be seen, but note that these are not pathognomonic of myeloma and can also be seen in reactive plasma cells:
    • Multinuclearity.
    • Flame cells (vermillion-staining glycogen-rich IgA).
    • Pseudo-Gaucher cells (overstuffed fibrils).
    • Russell bodies (cherry-red refractive, round bodies of crystallised immunoglobulins).
    • Mott cells which contain Russell bodies.
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x